In addition, AARS2 also displayed the consensus and same biological activity across almost all cancers, which harbored conspicuous positive relationship with proliferation‐related pathways such as G2M checkpoint, Wnt/β‐catenin pathway, and MYC Targets V2 (Figure 3A). This evidence concerns the gene MYC and cancer.